These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20177122)

  • 1. Responsiveness of different rating instruments in spinocerebellar ataxia patients.
    Schmitz-Hübsch T; Fimmers R; Rakowicz M; Rola R; Zdzienicka E; Fancellu R; Mariotti C; Linnemann C; Schöls L; Timmann D; Filla A; Salvatore E; Infante J; Giunti P; Labrum R; Kremer B; van de Warrenburg BP; Baliko L; Melegh B; Depondt C; Schulz J; du Montcel ST; Klockgether T
    Neurology; 2010 Feb; 74(8):678-84. PubMed ID: 20177122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.
    du Montcel ST; Charles P; Ribai P; Goizet C; Le Bayon A; Labauge P; Guyant-Maréchal L; Forlani S; Jauffret C; Vandenberghe N; N'guyen K; Le Ber I; Devos D; Vincitorio CM; Manto MU; Tison F; Hannequin D; Ruberg M; Brice A; Durr A
    Brain; 2008 May; 131(Pt 5):1352-61. PubMed ID: 18378516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia.
    Schmitz-Hübsch T; Giunti P; Stephenson DA; Globas C; Baliko L; Saccà F; Mariotti C; Rakowicz M; Szymanski S; Infante J; van de Warrenburg BP; Timmann D; Fancellu R; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Döhlinger S; Kremer B; Melegh B; Filla A; Klockgether T
    Neurology; 2008 Aug; 71(7):486-92. PubMed ID: 18695159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-rated health status in spinocerebellar ataxia--results from a European multicenter study.
    Schmitz-Hübsch T; Coudert M; Giunti P; Globas C; Baliko L; Fancellu R; Mariotti C; Filla A; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Ratzka S; Kremer B; Schulz JB; Klopstock T; Melegh B; du Montcel ST; Klockgether T
    Mov Disord; 2010 Apr; 25(5):587-95. PubMed ID: 20175183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scale for the assessment and rating of ataxia: development of a new clinical scale.
    Schmitz-Hübsch T; du Montcel ST; Baliko L; Berciano J; Boesch S; Depondt C; Giunti P; Globas C; Infante J; Kang JS; Kremer B; Mariotti C; Melegh B; Pandolfo M; Rakowicz M; Ribai P; Rola R; Schöls L; Szymanski S; van de Warrenburg BP; Dürr A; Klockgether T; Fancellu R
    Neurology; 2006 Jun; 66(11):1717-20. PubMed ID: 16769946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.
    Monte TL; Reckziegel ER; Augustin MC; Silva ASP; Locks-Coelho LD; Barsottini O; Pedroso JL; Vargas FR; Saraiva-Pereira ML; Leotti VB; Jardim LB;
    Cerebellum; 2017 Aug; 16(4):852-858. PubMed ID: 28456900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
    Jacobi H; Schaprian T; Schmitz-Hübsch T; Schmid M; Klockgether T;
    Ann Clin Transl Neurol; 2023 Oct; 10(10):1833-1843. PubMed ID: 37592453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients.
    Weyer A; Abele M; Schmitz-Hübsch T; Schoch B; Frings M; Timmann D; Klockgether T
    Mov Disord; 2007 Aug; 22(11):1633-7. PubMed ID: 17516493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-Related Quality of Life in Patients with Spinocerebellar Ataxia: a Validation Study of the EQ-5D-3L.
    Buchholz M; Weber N; Rädke A; Faber J; Schmitz-Hübsch T; Jacobi H; Xie F; Klockgether T; Michalowsky B; ;
    Cerebellum; 2024 Jun; 23(3):1020-1030. PubMed ID: 37713052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
    Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
    Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients.
    Schmitz-Hübsch T; Tezenas du Montcel S; Baliko L; Boesch S; Bonato S; Fancellu R; Giunti P; Globas C; Kang JS; Kremer B; Mariotti C; Melegh B; Rakowicz M; Rola R; Romano S; Schöls L; Szymanski S; van de Warrenburg BP; Zdzienicka E; Dürr A; Klockgether T
    Mov Disord; 2006 May; 21(5):699-704. PubMed ID: 16450347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; de Rivera FJR; Schöls L; Klockgether T; Bürk K; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2016 Dec; 15(13):1346-1354. PubMed ID: 27839651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
    Jacobi H; Bauer P; Giunti P; Labrum R; Sweeney MG; Charles P; Dürr A; Marelli C; Globas C; Linnemann C; Schöls L; Rakowicz M; Rola R; Zdzienicka E; Schmitz-Hübsch T; Fancellu R; Mariotti C; Tomasello C; Baliko L; Melegh B; Filla A; Rinaldi C; van de Warrenburg BP; Verstappen CC; Szymanski S; Berciano J; Infante J; Timmann D; Boesch S; Hering S; Depondt C; Pandolfo M; Kang JS; Ratzka S; Schulz J; Tezenas du Montcel S; Klockgether T
    Neurology; 2011 Sep; 77(11):1035-41. PubMed ID: 21832228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating an Ataxia Functional Composite Scale in spinocerebellar ataxia.
    Assadi M; Leone P; Veloski JJ; Schwartzman RJ; Janson CG; Campellone JV
    J Neurol Sci; 2008 May; 268(1-2):136-9. PubMed ID: 18191149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social economic costs and health-related quality of life in patients with degenerative cerebellar ataxia in Spain.
    López-Bastida J; Perestelo-Pérez L; Montón-Alvarez F; Serrano-Aguilar P
    Mov Disord; 2008 Jan; 23(2):212-7. PubMed ID: 17999424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.